The focus here: early signs and symptoms that can point to the diagnosis.
Sleep of Psoriasis Patients Improves with Intensive Topical Treatment
Emerging Agents in the Treatment of Rheumatic Diseases
Secukinumab 300 mg May Improve PsA or Active Psoriasis More Than 150 mg
Challenges with Step Therapy Protocols in Treating Rheumatoid Arthritis
FDA Grants Nipocalimab Fast Track Designation for Rare Fetal Disease, with Katie Abouzahr, MD
International Working Group Releases First Guideline for Osteoporosis in Men
